| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/10/2008 | US20080085269 Vaccine And Method For Treatment Of Neurodegenerative Diseases |
| 04/10/2008 | US20080085244 comparing levels with untreated ovariectomized animal determining amount of an estrogen to reduce amyloid peptides in brain of an animal without affecting soluble APP level; administering test compound to an ovariectomized non-human animal; beta.17-estradiol reversed ovx-associated levels; Alzheimer's |
| 04/10/2008 | DE112004001520B4 Verwendung eines Lipidglyzerids festgelegter Struktur zur Herstellung eines Medikamentes zur Behandlung der multiplen Sklerose Use of a Lipidglyzerids fixed structure for producing a medicament for the treatment of multiple sclerosis |
| 04/10/2008 | DE102006048130A1 Transdermales therapeutisches System mit zweiphasigem Freisetzungsprofil Transdermal therapeutic system with two-phase release profile |
| 04/10/2008 | DE102006045762A1 Grüntee-Arzneimittel-Extrakt, insbesondere zur Prophylaxe und Behandlung von Erkrankungen des zentralen Nervensystems, dessen Verwendung zur Herstellung eines Arzneimittels sowie Verfahren zu dessen Herstellung Green tea drug extract, in particular for the prophylaxis and treatment of diseases of the central nervous system, its use for producing a medicament and methods for the preparation thereof |
| 04/10/2008 | DE10066235B4 Targeted inhibition of gene expression by administration of double stranded oligoribonucleotide to a cell, useful for treating humans, animals and plants against viral infection |
| 04/10/2008 | CA2667668A1 Amorphous asenapine and processes for preparing same |
| 04/10/2008 | CA2665117A1 Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy |
| 04/10/2008 | CA2665083A1 Mglur5 modulators |
| 04/10/2008 | CA2664959A1 Use of chlorine guanabenz derivatives for treating prion-based diseases |
| 04/10/2008 | CA2664842A1 Arginine derivatives with np-i antagonistic activity |
| 04/10/2008 | CA2664702A1 Mixed orl1/mu-agonists for the treatment of pain |
| 04/10/2008 | CA2664398A1 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/09/2008 | EP1908830A1 Non-human gene-disrupted animal having adam11 gene disruption |
| 04/09/2008 | EP1908781A2 Modulation of immune response and methods based thereon |
| 04/09/2008 | EP1908765A1 Thienopyrimidine derivative |
| 04/09/2008 | EP1908752A1 Novel 2-quinolone derivative |
| 04/09/2008 | EP1908467A1 Herpesvirus-derived therapeutic agent for pain |
| 04/09/2008 | EP1908465A1 Use of chlorine guanabenz derivatives for treating prion-based diseases |
| 04/09/2008 | EP1908464A1 Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases |
| 04/09/2008 | EP1908461A1 Use of (1S, 2R) enantiomer of milnacipran for the preparation of a medicine |
| 04/09/2008 | EP1907398A1 Therapeutic agents |
| 04/09/2008 | EP1907382A1 Nitrocatechol derivatives as comt inhibitors |
| 04/09/2008 | EP1907372A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 04/09/2008 | EP1907365A1 Salts of substituted pyrazoline compounds, their preparation and use as medicaments |
| 04/09/2008 | EP1907364A1 Aripiprazole salts |
| 04/09/2008 | EP1907362A1 Amide derivatives as kinase inhibitors |
| 04/09/2008 | EP1906959A1 Novel epilepsy treatment |
| 04/09/2008 | EP1906953A1 Acid and base salt forms of gaboxadol |
| 04/09/2008 | EP1906944A1 Schisandrin b preparation |
| 04/09/2008 | EP1906917A2 Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent |
| 04/09/2008 | EP1450796B1 Benzothiazole derivatives |
| 04/09/2008 | EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 04/09/2008 | EP1414444B1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 04/09/2008 | EP1173767B1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 04/09/2008 | EP1135106B1 Sustained release matrix systems for highly soluble drugs |
| 04/09/2008 | EP1124551B1 Delta 9 tetrahydrocannabinol (delta 9 thc) solution metered dose inhalers and methods of use |
| 04/09/2008 | EP1036175B1 Human brain derived kcnq2 potassium channel |
| 04/09/2008 | CN101160403A Molecules for transporting a compound across the blood-brain barrier |
| 04/09/2008 | CN101160304A Substituted aryl 1,4-pyrazine derivatives |
| 04/09/2008 | CN101160281A Crystalline forms of pregabalin |
| 04/09/2008 | CN101160128A Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient |
| 04/09/2008 | CN101160127A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy |
| 04/09/2008 | CN101160120A Sedative effect-providing agent and sedative fragrance composition containing the same |
| 04/09/2008 | CN101157716A Dicarbon drop freedelane triterpenoid and preparation method and uses thereof |
| 04/09/2008 | CN101156944A Cleavage liquid for preventing and curing nervus energy disease scathing nervus stem cell |
| 04/09/2008 | CN101156943A Secreted neural apoptosis inhibiting proteins |
| 04/09/2008 | CN101156941A A drug rehabilitation medicine for preventing suction again |
| 04/09/2008 | CN101156935A Plants active component composition for curing sick headache as well as its preparing method and application |
| 04/09/2008 | CN101156922A A traditional Chinese medicine composition for treating insomnia |
| 04/09/2008 | CN101156912A A compound recipe traditional Chinese medicine composition and its purpose |
| 04/09/2008 | CN101156897A A medicine for treating zoster sequela neuralgia |
| 04/09/2008 | CN101156895A Medicine for curing headache and its preparing method |
| 04/09/2008 | CN101156880A A preparation method of traditional Chinese medicine ligusticum wallichii injection |
| 04/09/2008 | CN101156877A A sobering-up agent |
| 04/09/2008 | CN101156870A A composition for improving growth development and help in improving anamnesis as well as its preparation method |
| 04/09/2008 | CN101156859A Hydrochloric acid chlorine imipramine sublingual piece and method for making same |
| 04/09/2008 | CN101156855A Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders |
| 04/09/2008 | CN101156843A A capsule for preventing and treating Alzheimer disease as well as its preparing method |
| 04/09/2008 | CN101156840A Inhibitors of oleamide hydrolase |
| 04/09/2008 | CN101156835A Preparation method of hypericin oral liquid |
| 04/09/2008 | CN101156713A A tobacco for give up smoking and its using method |
| 04/09/2008 | CN101156690A Sleep-regulating and anti-senile nutrition health products and method for making same |
| 04/09/2008 | CN101156688A Health food for sleep-regulating function and its preparation method |
| 04/09/2008 | CN100379752C Antagonists of BMP and TGF beta signalling pathway |
| 04/09/2008 | CN100379737C Thioxanthine derivatives as myeloperoxidase inhibitors |
| 04/09/2008 | CN100379735C 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents |
| 04/09/2008 | CN100379734C Azaindoles |
| 04/09/2008 | CN100379728C Novel imidazole compounds, method for preparing same and use thereof as medicines |
| 04/09/2008 | CN100379719C Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 04/09/2008 | CN100379450C Method of expressing antigen on the surface of an antigen-presenting cell by photochemical internalisation |
| 04/09/2008 | CN100379448C 蛋白酶抑制剂 Protease inhibitors |
| 04/09/2008 | CN100379446C Erythropoietin ameliorates chemotheapy-induced toxicity in vivo |
| 04/09/2008 | CN100379439C Health product for enhancing immunity and soothing the nerves |
| 04/09/2008 | CN100379426C Pyrimidine nucleoside and pharmacy usage of pyrimidine nucleotide precursor |
| 04/09/2008 | CN100379420C Long acting slow releasing drug addiction eliminating prepn and its preparation process and use |
| 04/09/2008 | CN100379418C The use of antimuscarinic drugs |
| 04/09/2008 | CN100379416C Stable solid medicinal composition for oral administration. |
| 04/09/2008 | CN100379414C Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells |
| 04/09/2008 | CN100379413C Preparation for improving the action of receptors |
| 04/09/2008 | CN100379412C Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia |
| 04/08/2008 | US7355093 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders |
| 04/08/2008 | US7355081 androgen receptor antagonists; certain cancers, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired |
| 04/08/2008 | US7355080 Reacting 1-bromo-3,5-dimethyl adamantane and urea/formic acid, with formic acid also acting as the solvent; hydrolyzing with aqueous inorganic acid; alkalifying, and extracting and acidifying with hydrochloric acid; performed in homogeneous phase under mild conditions |
| 04/08/2008 | US7355054 Indole derivatives |
| 04/08/2008 | US7355052 Melanocortin receptors; analgesivs; antiinflammatory agents; eating disorders; psycological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents |
| 04/08/2008 | US7355047 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 04/08/2008 | US7355042 Sleep disorders; side effect reduction |
| 04/08/2008 | US7354947 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
| 04/08/2008 | US7354943 Statine derivatives for the treatment of Alzheimer's disease |
| 04/08/2008 | US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes |
| 04/08/2008 | US7354940 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12 |
| 04/08/2008 | US7354939 Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto |
| 04/08/2008 | US7354936 2-phenylpyran-4-one derivatives |
| 04/08/2008 | US7354920 Aryl and heteroaryl morpholine derivatives |
| 04/08/2008 | US7354919 Isoxazole compositions useful as inhibitors of ERK |
| 04/08/2008 | US7354914 1-[3-Methyl-1-(5-methyl-6-oxo-benzo[b]-1,4-oxazepin-7-ylcarbamoyl)-butyl]-cyclohexanecarboxylic acid amide; inhibit processing of amyloid precursor protein (production of A beta -peptide); neurological disorders related to beta -amyloid production: Alzheimer's disease, Down's Syndrome |
| 04/08/2008 | US7354769 Comparing the ability of N,N-bis(3-D-gluconamidopropyl)-deoxycholamine to inhibit binding of IGFBP-1 or -3 to IGF-1 with the ability of a candidate indirect agonist of IGF-1 to identify effective agonists |
| 04/08/2008 | US7354738 isolated polypeptide modulates activity of nuclear receptor/ nuclear respiratory factor, brown adipose cell determination/differentiation, mitochondrial activity, biogenesis, fatty acid oxidation |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |